Physician profile
Robert L Buckley
NPI 1356314702
$1,311.37
in general payments reported to CMS, 2019-2025
21 companies · $121 in 2025
The $121 reported for 2025 was less than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $278 · 2020: $82.29 · 2021: $159 · 2022: $210 · 2023: $219 · 2024: $241 · 2025: $121.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $581.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $581.30 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $263.81 | 2019-2024 | Airsupra |
| Abbvie INC. | $145.29 | 2021-2023 | Ubrelvy, Qulipta |
| Novo Nordisk INC | $140.48 | 2023 | Wegovy |
| Boston Scientific Corporation | $119.99 | 2021-2022 | |
| Pfizer INC. | $96.99 | 2019-2024 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $78.48 | 2020-2025 | Ofev |
| Supernus Pharmaceuticals, INC. | $72.17 | 2024-2025 | Qelbree |
| Ironshore Pharmaceuticals INC. | $65.99 | 2019 | |
| Takeda Pharmaceuticals U.S.A., INC. | $49.97 | 2019-2022 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $42.07 | 2020 | |
| Glaxosmithkline, LLC. | $38.42 | 2021-2022 | |
| Exact Sciences Corporation | $33.54 | 2025 | Cologuard Collection Kit |
| Idorsia Pharmaceuticals US INC | $30.92 | 2022-2023 | Quviviq |
| Lilly USA, LLC | $25.57 | 2022 | |
| Sanofi Pasteur INC. | $19.10 | 2019 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Harmony Biosciences LLC | $17.06 | 2025 | |
| Shield Therapeutics INC | $15.13 | 2024 | |
| Amgen INC. | $15.06 | 2020 | |
| Merck Sharp & Dohme LLC | $14.97 | 2024 | Vaxelis, Gardasil 9, Vaqta |
| Linus Health, INC. | $14.46 | 2023 | |
| Eisai INC. | $11.90 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Buckley listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.